---
layout: post
title: "百济神州：百悦泽新适应症上市申请获得受理"
date: 2022-01-20 18:04:54 +0800
categories: emnews
tags: 东财滚动新闻
---
> 百济神州(688235)1月20日晚间公告，公司近日收到国家药监局签发的《受理通知书》，百悦泽(泽布替尼胶囊)用于治疗华氏巨球蛋白血症成人患者的新适应症上市申请获得受理。（证券时报）

<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.688235" data-code="688235|1|1" data-code2="688235|1|23|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.688235&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 688235_0" data-code="K 688235|1|1" data-code2="K 688235|1|23|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.06160" data-code="06160|116|5" data-code2="06160|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.06160&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 06160_0" data-code="K 06160|116|5" data-code2="K 06160|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/105.BGNE" data-code="BGNE|105|7" data-code2="BGNE|105|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=105.BGNE&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 BGNE_0" data-code="K BGNE|105|7" data-code2="K BGNE|105|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p><span id="stock_105.BGNE"><a href="http://quote.eastmoney.com/unify/r/105.BGNE" class="keytip" data-code="105,BGNE">百济神州</a></span><span id="quote_105.BGNE"></span>(688235)1月20日晚间<span id="Info.3332"><a href="http://data.eastmoney.com/notices/" class="infokey">公告</a></span>，公司近日收到国家药监局签发的《受理通知书》，百悦泽(泽布替尼胶囊)用于治疗华氏巨球蛋白血症成人患者的新适应症上市申请获得受理。<br /></p><p class="em_media">（文章来源：<span id="bk_90.BK0473"><a href="http://quote.eastmoney.com/unify/r/90.BK0473" class="keytip" data-code="90,BK0473">证券</a></span><span id="bkquote_90.BK0473"></span>时报）</p>

<http://finance.eastmoney.com/news/1354,202201202255315039.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)